We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Agronomics Limited | LSE:ANIC | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.10 | -1.67% | 5.90 | 5.90 | 6.10 | 6.00 | 6.00 | 6.00 | 1,407,346 | 16:35:17 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investors, Nec | 30.88M | 22.37M | 0.0222 | 2.70 | 60.56M |
From Jul 2019 to Jul 2024
TIDMPEBI
RNS Number : 2799V
Port Erin Biopharma Investments Ltd
15 April 2016
Port Erin Biopharma Investments Limited
("Port Erin" or the "Company")
Change of Adviser
The Board of Port Erin, the AIM quoted company focused on investing in the biotechnology and biopharmaceutical sectors, is pleased to announce the appointment of Northland Capital Partners Limited as the Company's Nominated Adviser and Joint Broker with immediate effect.
Enquiries
Hot Features
Premium
Port Erin Biopharma Investments +44(0) 1624
Limited 639396
Denham Eke
+44(0) 203
Northland Capital Partners Limited 861 6625
Nominated Adviser and Joint Broker
Matthew Johnson / David Hignell
/ Gerry Beaney (Corporate Finance)
John Howes / Rob Rees (Broking)
+44(0) 207
Peterhouse Corporate Finance Limited 469 0936
Joint Broker
Lucy Williams
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPBLGDSBXBBGLS
(END) Dow Jones Newswires
April 15, 2016 02:00 ET (06:00 GMT)
1 Year Agronomics Chart |
1 Month Agronomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
